Telemonitoring for Heart Failure
(Medly Titrate Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether telemonitoring (remote health tracking via smartphone) can manage heart failure more effectively than regular in-office visits. The focus is on adjusting heart failure medications safely and efficiently by providing real-time data to doctors and patients. Suitable candidates have stable heart failure, are not yet on maximum medication doses, and receive care at a specific heart clinic in Toronto. Participants will either use the telemonitoring system or continue with their usual in-office visits for comparison. As an unphased study, this trial offers a unique opportunity to contribute to innovative heart failure care solutions.
Do I need to stop my current medications for the trial?
The trial does not specify if you need to stop your current medications. However, it focuses on adjusting heart failure medications to reach target doses, so you may need to continue your current heart failure medications while they are adjusted.
What prior data suggests that telemonitoring is safe for heart failure patients?
Research has shown that heart failure patients generally receive telemonitoring well. Studies have found that telemonitoring can reduce deaths and hospital visits, suggesting it is relatively safe.
Detailed information about specific side effects from telemonitoring remains limited. However, its ability to lower hospital visits indicates it is a helpful and safe way to manage heart failure at home. Although large studies have not yet tested telemonitoring, smaller studies suggest it improves health outcomes without major safety concerns.12345Why are researchers excited about this trial?
Researchers are excited about telemonitoring for heart failure because it offers a fresh approach compared to traditional in-office visits. Unlike standard management strategies that require patients to physically go to their doctor's office, telemonitoring uses remote titration management via telephone and data from devices like the Medly system. This method allows for continuous monitoring and adjustment of treatment from the comfort of a patient's home, potentially leading to more timely interventions and better management of heart failure symptoms. This can significantly improve patient convenience and may lead to better overall health outcomes.
What evidence suggests that telemonitoring is effective for heart failure?
This trial will compare telemonitoring with standard in-office visits for managing heart failure. Studies have shown that telemonitoring, which participants in the study group will receive, can help people with heart failure by lowering death rates and reducing hospital readmissions. Research indicates that remote monitoring tools allow for better management of the condition by providing healthcare providers with real-time information. This information helps doctors adjust medications more effectively and quickly. Telemonitoring has improved outcomes by preventing hospital readmissions and offering a reliable way for patients to manage their health at home. Overall, evidence supports telemonitoring as a valuable tool in treating heart failure.25678
Who Is on the Research Team?
Emily Seto, PhD
Principal Investigator
University Health Network, Toronto
Are You a Good Fit for This Trial?
This trial is for adults with heart failure (NYHA Class II-III) who are not yet on target doses of heart failure medication, can give informed consent, speak and read English well enough to use the Medly app, and have a left ventricular ejection fraction of 40% or less. They should be stable with no recent hospitalizations and able to use the telemonitoring equipment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive telemonitoring-based medication titration for heart failure management
Follow-up
Participants are monitored for safety and effectiveness after treatment
Implementation Evaluation
Qualitative interviews with patients and providers to assess implementation barriers and facilitators
What Are the Treatments Tested in This Trial?
Interventions
- Telemonitoring
Trial Overview
The study tests if using a smartphone-based telemonitoring system called Medly can help patients adjust their heart failure medications better than regular in-office visits. It's a randomized controlled trial comparing these two strategies at the Peter Munk Cardiac Centre.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Remote titration management strategy, consisting of telephone contacts, which will utilize data from the Medly system.
Standard titration management strategy, consisting of regular in-office visits.
Telemonitoring is already approved in Canada, European Union, United States for the following indications:
- Heart Failure
- Diabetes
- Hypertension
- COPD
- Depression
- Heart Failure
- Diabetes
- Hypertension
- COPD
- Heart Failure
- Diabetes
- Hypertension
- COPD
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor
Citations
Telemonitoring in heart failure patients: Systematic review ...
Home telemonitoring has been used as a modality to prevent readmission and improve outcomes for patients with heart failure.
Telehealth care and remote monitoring strategies in heart ...
This meta-analysis provides insights about telemonitoring on heart failure patients. Telemonitoring reduces mortality and rehospitalization in hearth failure ...
3.
uscjournal.com
uscjournal.com/articles/remote-monitoring-heart-failure-revolutionizing-patient-management-and-outcomes?language_content_entity=enRemote Monitoring in Heart Failure: Patient Management ...
Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: BEAT-HF. JAMA Intern Med 2016;176:310–8.
Effectiveness of Remote Patient Monitoring After Discharge ...
Importance It remains unclear whether telemonitoring approaches provide benefits for patients with heart failure (HF) after hospitalization.
Remote Monitoring of Patients With Heart Failure
Telemonitoring and home telehealth appear generally effective in reducing heart failure rehospitalization and mortality.
Telemonitoring for heart failure: a meta-analysis - PMC
Telemonitoring modalities in heart failure (HF) have been proposed as being essential for future organization and transition of HF care, ...
Remote Monitoring for Heart Failure Management at Home
Early telemonitoring of weights and symptoms did not decrease heart failure hospitalizations but helped identify steps toward effective monitoring programs.
Telemonitoring in Patients with Heart Failure
Small studies suggest that telemonitoring may improve heart-failure outcomes, but its effect in a large trial has not been established.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.